Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors

Journal of Immunology

Volumn 161, Issue 5, 1998, Pages 2586-2593

  Elenkov, Ilia J ^a,b   Webster, Elizabeth ^b   Papanicolaou, Dimitris A ^b   Fleisher, Thomas A ^c   Chrousos, George P ^b   Wilder, Ronald L ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; CYCLIC AMP; CYTOKINE; DIMAPRIT; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR; HISTAMINE H2 RECEPTOR AGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; HISTAMINE H3 RECEPTOR ANTAGONIST; INTERLEUKIN 10; INTERLEUKIN 12; MEPYRAMINE MALEATE; NEUTRALIZING ANTIBODY; RECOMBINANT INTERLEUKIN 12; THIOPERAMINE MALEATE; UNCLASSIFIED DRUG;

ALLERGY; ARTICLE; BLOOD CULTURE; ENZYME INHIBITION; HISTAMINE RELEASE; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; RECEPTOR BLOCKING; STAPHYLOCOCCUS AUREUS;

ADULT; CELLS, CULTURED; CIMETIDINE; CYCLIC AMP; DIMAPRIT; DRUG SYNERGISM; FEMALE; HISTAMINE; HISTAMINE AGONISTS; HISTAMINE H2 ANTAGONISTS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12; LIPOPOLYSACCHARIDES; MALE; MONOCYTES; RECEPTORS, HISTAMINE H2; TH1 CELLS; TH2 CELLS;

EID: 0032167605     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Kobayashi, M., L. Fitz, M. Ryan, R. M. Hewick, S.C. Clark, S. Chan, R. Loudon, F. Sherman, B. Perussia, and G. Trinchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170:827.
2. Abbas, A. K., K. M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature 383:787.
3. Segal, B. M., D. M. Klinman, and E. M. Shevach. 1997. Microbial products induce autoimmune disease by an IL-12-dependent pathway. J. Immunol. 158:5087.
4. O'Hara, R. M., Jr., S. L. Henderson, and A. Nagelin. 1996. Prevention of a Th1 disease by a Th1 cytokine: IL-12 and diabetes in NOD mice. Ann. NY Acad. Sci. 795:241.
5. Germann, T., H. Hess, J. Szeliga, and E. Rude. 1996. Characterization of the adjuvant effect of IL-12 and efficacy of IL-12 inhibitors in type II collagen-induced arthritis. Ann. NY Acatl. Sci. 795:227.
6. Chougnet, C., T. A. Wynn, M. Clerici, A. L. Landay, H. A. Kessler, J. Rusnak, G. P. Melcher, A. Sher, and G. M. Shearer. 1996. Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus. J. Infect. Dis. 174:46.
7. Colombo, M. P., M. Vagliani, F. Spreafico, M. Parenza, C. Chiodoni, C. Melani, and A. Stoppacciaro. 1996. Amount of interleukin 12 available at the tumor site is critical for tumor regression. Cancer Res. 56:2531.
8. Mosmann, T. R. 1994. Properties and functions of interleukin-10. Adv. Immunol. 56:1.
9. de Vries, J. E. 1995. Immunosuppressive and anti-inflammatory properties of interleukin 10. Ann. Med. 27:537.
10. Pajkrt, D., T. van der Poll, M. Levi, D. L. Cutler, M. B. Affrime, A. van den Ende, J. W. ten Cate, and S. J. van Deventer. 1997. Interleukin-10 inhibits activation of coagulation and fibrinolysis during human endotoxemia. Blood 89:2701.
11. Schreiber, S., T. Heinig, H. G. Thiele, and A. Raedler. 1995. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterology 108:1434.
12. van Roon, J. A., J. L. van Roy, F. H. Gmelig-Meyling, F. P. Lafeber, and J. W. Bijlsma. 1996. Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4. Arthritis Rheum. 39:829.
13. Chen, Q., V. Daniel, D. W. Maher, and P. Hersey. 1994. Production of IL-10 by melanoma cells: examination of its role in immunosuppression mediated by melanoma. Int. J. Cancer 56:755.
14. Hagiwara, E., M. F. Gourley, S. Lee, and D. K. Klinman. 1996. Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10: interferon-gamma-secreting cells in the peripheral blood. Arthritis Rheum. 39:379.
15. Karttunen, R. A., T. J. Karttunen, M. M. Yousfi, H. M. el-Zimaity, D. Y. Graham, and F. A. el-Zaatari. 1997. Expression of mRNA for interferon-gamma, interleukin-10, and interleukin-12 (p40) in normal gastric mucosa and in mucosa infected with Helicobacter pylori. Scand. J. Gastroenterol. 32:22.
16. Garcia-Caballero, M., I. Nunez de Castro, J. Kusche, and C. Vara-Thorbeck. 1993. Histamine metabolism in human breast and colorectal cancer: Its effects on other host tissues. Adv. Biosci. 89:273.
17. Matsumoto, S. 1995. Cimetidine and survival with colorectal cancer [letter; comment]. Lancet 346:115.
18. Morris, D. L., and W. J. Adams. 1995. Cimetidine and colorectal cancer: old drug, new use? Nat. Med. 1:1243.
19. Wilson, B.M., A. Severn, N.T. Rapson, J. Chana, and P. A. Hopkins. 1991. Convenient human whole blood culture system for studying the regulation of tumour necrosis factor release by bacterial lipopolysaccharide. J. Immunol. Methods 139:233.
20. van der Pouw Kraan, T. C., L. C. Boeije, R. J. Smeenk, J. Wijdenes, and L. A. Aarden. 1995. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 181:775.
21. Ianaro, A., C. A. O'Donnell, M. Di Rosa, and F. Y. Liew. 1994. A nitric oxide synthase inhibitor reduces inflammation, down-regulates inflammatory cytokines and enhances interleukin-10 production in carrageenin-induced oedema in mice. Immunology 82:370.
22. Elenkov, I. J., D. A. Papanicolaou, R. L. Wilder, and G. P. Chrousos. 1996. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proc. Assoc. Am. Physicians. 108:374.
23. Smit, M.J., R. Leurs, S.R. Shukrula, A. Bast, and H. Timmerman. 1994. Rapid desensitization of the histamine H2 receptor on the human monocytic cell line U937. Eur. J. Pharmacol. 288:17.
24. Fearon, D.T and R .M. Locksley. 1996. The instructive role of innate immunity in the acquired immune response. Science 272:50.
25. Trinchieri, G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251.
26. Vannier, E., L. C. Miller, and C. A. Dinarello. 1991. Histamine suppresses gene expression and synthesis of tumor necrosis factor alpha via histamine H2 receptors. J. Exp. Med. 174:281.
27. 3 receptors. Am. J. Respir. Cell Mol. Biol. 14:620.
28. Delneste, Y., P. Lassalle, P. Jeannin, M. Joseph, A. B. Tonnel, and P. Gosset. 1994. Histamine induces IL-6 production by human endothelial cells. Clin. Exp. Immunol. 98:344.
29. Lagier, B., B. Lebel, J. Bousquet, and J. Pene. 1997. Different modulation by histamine of IL-4 and interferon-gamma (IFN-γ) release according to the phenotype of human Th0, Th1 and Th2 clones. Clin. Exp. Immunol. 108:545.
30. Kimata, H., M. Fujimoto, C. Ishioka, and A. Yoshida. 1996. Histamine selectively enhances human immunoglobutin E (IgE) and IgG4 production induced by anti-CD58 monoclonal antibody. J. Exp. Med. 184:357.
31. Beer, D. J., C. A. Dinarello, L. J. Rosenwasser, and R. E. Rocklin. 1982. Human monocyte-derived soluble product(s) has an accessory function in the generation of histamine- and concanavalin A-induced suppressor T cells. J. Clin. Invest. 70:393.